Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study

OBJECTIVE: Plasma dipeptidyl peptidase-4 (DPP4) levels were significantly lower in patients with colorectal and liver cancers, and animal studies also showed DPP4 inhibitors (DPP4is) have procarcinogenic effects in colorectal cancer. Until now, whether DPP4is therapy affects the progression of liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Chu-Lin, Juan, Shu-Hui, Li, Ching-Hao, Chen, Hsi-Hsien, Kao, Chih-Chin, Chen, Li-Ying, Chien, Li-Nien, Fang, Te-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120816/
https://www.ncbi.nlm.nih.gov/pubmed/35600378
http://dx.doi.org/10.3389/fonc.2022.840142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120816/
https://www.ncbi.nlm.nih.gov/pubmed/35600378
http://dx.doi.org/10.3389/fonc.2022.840142

Ejemplares similares